Swiss Diabetes Registry - SwissDiab Study
About this study
Currently, the estimated number of people with diabetes mellitus is approximately 387 million people worldwide. Due to population growth, urbanization, ageing and the rising prevalence of obesity the numbers of individuals with diabetes is increasing likewise. It has been shown that improving glycemic control is associated with a reduction in late complications of diabetes, such as cardiovascular and microvascular diseases. Therefore, treatment guidelines were established internationally by large and renowned associations and adopted by many countries. For Switzerland only sparse data exist on the actual implementation of such recommendations and on patient's well-being. The Swiss Diabetes Registry - SwissDiab Study is a prospective cohort study aiming at including and collecting data of virtually all patients regularly seen and treated at the study centers (≈ 500 patients each), irrespective of type, duration of diabetes or treatment . This allows the evaluation of diabetes treatment strategies at these centers. Furthermore, risk indicators for micro- and macrovascular complications, mortality as well as costs and quality of life will be assessed. Data will be recorded through an internet-based, electronic database specifically designed for this study. At a later perspective it is planned to extend data collection to general practitioner/family doctor networks in order to include a larger and more representative sample of patients with diabetes in Switzerland.
- Condition
- Diabetes Mellitus
- Sponsor
- Insel Gruppe AG, University Hospital Bern
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 5
- Minimum age: 18 years
- Study condition: Diabetes Mellitus
- Age \> 18 years
- Diagnosis of diabetes mellitus according to ADA criteria
- Informed consent
Exclusion 1
- Patients with gestational diabetes mellitus, patients unable to give informed consent, legally incompetent or incapable to comply with the study terms and conditions as well as patients with significantly reduced life expectancy (\<1 year) will be excluded
Where
4 sites, 4 recruiting
Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung, Inselspital Bern
Bern, Switzerland
Service d'endocrinologie, diabétologie et métabolisme
Lausanne, Switzerland
Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen, Kantonsspital St.Gallen
Sankt Gallen, Switzerland
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich
Zurich, Switzerland
Contact
-
Markus Laimer, PD Dr. med.
+41 31 632 30 62 Markus.Laimer@insel.ch
-
Christoph Stettler, Prof.
+41 31 632 40 70 christoph.stettler@insel.ch
Potential match only. Final eligibility is determined by the study team.